Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial Intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.

Multiple illustrations of bones and joints of the human body

Missed or delayed diagnosis of fractures on X-ray is a common error with potentially serious implications for the patient. Lack of timely access to expert opinion as the growth in imaging volumes continues to outpace radiologist recruitment only makes the problem worse.

The study in Radiology finds that AI may help address this problem by acting as an aid to radiologists, helping to speed and improve fracture diagnosis.

"We found that AI performed with a high degree of accuracy, comparable to clinician performance," said study lead author Rachel Kuo, NIHR Academic Clinical Fellow and Plastic and Reconstructive Surgery Registrar, who is part of the Furniss Group at the Botnar Institute for Musculoskeletal Sciences. "Importantly, we found this to be the case when AI was validated using independent external datasets, suggesting that the results may be generalizable to the wider population."

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.